These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22432619)

  • 21. Engineering of pharmaceutical materials: an industrial perspective.
    Chow K; Tong HH; Lum S; Chow AH
    J Pharm Sci; 2008 Aug; 97(8):2855-77. PubMed ID: 17943933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG; Law D; Schmitt EA; Qiu Y
    Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes.
    Févotte G; Calas J; Puel F; Hoff C
    Int J Pharm; 2004 Apr; 273(1-2):159-69. PubMed ID: 15010140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The integration of solid-form informatics into solid-form selection.
    Feeder N; Pidcock E; Reilly AM; Sadiq G; Doherty CL; Back KR; Meenan P; Docherty R
    J Pharm Pharmacol; 2015 Jun; 67(6):857-68. PubMed ID: 25891945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical considerations for the qualitative and quantitative determination of process-induced disorder in crystalline solids.
    Newman A; Zografi G
    J Pharm Sci; 2014 Sep; 103(9):2595-2604. PubMed ID: 24623166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient co-crystal screening using solution-mediated phase transformation.
    Zhang GG; Henry RF; Borchardt TB; Lou X
    J Pharm Sci; 2007 May; 96(5):990-5. PubMed ID: 17455356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of mid-IR spectroscopy for the characterization of pharmaceutical systems.
    Van Eerdenbrugh B; Taylor LS
    Int J Pharm; 2011 Sep; 417(1-2):3-16. PubMed ID: 21167267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
    Li H; Kiang YH; Jona J
    Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of solid state properties on developability assessment of drug candidates.
    Huang LF; Tong WQ
    Adv Drug Deliv Rev; 2004 Feb; 56(3):321-34. PubMed ID: 14962584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the bulk properties of pharmaceutical solids using nonlinear optics--a review.
    Lee CJ; Strachan CJ; Manson PJ; Rades T
    J Pharm Pharmacol; 2007 Feb; 59(2):241-50. PubMed ID: 17270077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 35. Solid-state NMR in the analysis of drugs and naturally occurring materials.
    Paradowska K; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():27-42. PubMed ID: 24173236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight to the thermodynamic stability of molecular crystals through crystallographic studies of a multipolymorph system.
    Ng AT; Lai C; Dabros M; Gao Q
    J Pharm Sci; 2014 Nov; 103(11):3423-3431. PubMed ID: 25252084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early chemical development at Legacy Wyeth Research.
    O'Brien MK; Kolb M; Connolly TJ; McWilliams JC; Sutherland K
    Drug Discov Today; 2011 Jan; 16(1-2):81-8. PubMed ID: 21111844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deliquescence of pharmaceutical systems.
    Mauer LJ; Taylor LS
    Pharm Dev Technol; 2010 Dec; 15(6):582-94. PubMed ID: 19895256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
    Hausman DS; Cambron RT; Sakr A
    Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
    Pöllänen K; Häkkinen A; Reinikainen SP; Rantanen J; Karjalainen M; Louhi-Kultanen M; Nyström L
    J Pharm Biomed Anal; 2005 Jun; 38(2):275-84. PubMed ID: 15925219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.